General Information of Target

Target ID LDTP13207
Target Name Ephrin type-A receptor 6 (EPHA6)
Gene Name EPHA6
Gene ID 285220
Synonyms
EHK2; HEK12; Ephrin type-A receptor 6; EC 2.7.10.1; EPH homology kinase 2; EHK-2; EPH-like kinase 12; EK12
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MLRTCYVLCSQAGPPSRGWQSLSFDGGAFHLKGTGELTRALLVLRLCAWPPLVTHGLLLQ
AWSRRLLGSRLSGAFLRASVYGQFVAGETAEEVKGCVQQLRTLSLRPLLAVPTEEEPDSA
AKSGEAWYEGNLGAMLRCVDLSRGLLEPPSLAEASLMQLKVTALTSTRLCKELASWVRRP
GASLELSPERLAEAMDSGQNLQVSCLNAEQNQHLRASLSRLHRVAQYARAQHVRLLVDAE
YTSLNPALSLLVAALAVRWNSPGEGGPWVWNTYQACLKDTFERLGRDAEAAHRAGLAFGV
KLVRGAYLDKERAVAQLHGMEDPTQPDYEATSQSYSRCLELMLTHVARHGPMCHLMVASH
NEESVRQATKRMWELGIPLDGTVCFGQLLGMCDHVSLALGQAGYVVYKSIPYGSLEEVIP
YLIRRAQENRSVLQGARREQELLSQELWRRLLPGCRRIPH
Target Type
Literature-reported
Target Bioclass
Enzyme
Family
Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily
Subcellular location
Membrane
Function
Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling.
TTD ID
T08647
Uniprot ID
Q9UF33
DrugMap ID
TTFAHWI
Ensemble ID
ENST00000502694.1
HGNC ID
HGNC:19296
ChEMBL ID
CHEMBL4526

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 2 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C690(1.99)  LDD3401  [1]
BTD
 Probe Info 
C4(1.24)  LDD2089  [2]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0498  BS-3668 MDA-MB-231 C4(1.18)  LDD2091  [2]
 LDCM0022  KB02 CC-LP-1 C690(2.44)  LDD2298  [1]
 LDCM0023  KB03 CC-LP-1 C690(3.06)  LDD2715  [1]
 LDCM0024  KB05 RD C690(1.99)  LDD3401  [1]
 LDCM0496  Nucleophilic fragment 11a MDA-MB-231 C4(1.24)  LDD2089  [2]

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
2 Nucleophilic covalent ligand discovery for the cysteine redoxome. Nat Chem Biol. 2023 Nov;19(11):1309-1319. doi: 10.1038/s41589-023-01330-5. Epub 2023 May 29.
Mass spectrometry data entry: PXD039908 , PXD029761